317 related articles for article (PubMed ID: 30942954)
1. Variable cytoplasmic actin expression impacts the sensitivity of different dystrophin-deficient mdx skeletal muscles to eccentric contraction.
Lindsay A; Southern WM; McCourt PM; Larson AA; Hodges JS; Lowe DA; Ervasti JM
FEBS J; 2019 Jul; 286(13):2562-2576. PubMed ID: 30942954
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
[TBL] [Abstract][Full Text] [Related]
3. Consequences of the combined deficiency in dystrophin and utrophin on the mechanical properties and myosin composition of some limb and respiratory muscles of the mouse.
Deconinck N; Rafael JA; Beckers-Bleukx G; Kahn D; Deconinck AE; Davies KE; Gillis JM
Neuromuscul Disord; 1998 Aug; 8(6):362-70. PubMed ID: 9713852
[TBL] [Abstract][Full Text] [Related]
4. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.
Baker PE; Kearney JA; Gong B; Merriam AP; Kuhn DE; Porter JD; Rafael-Fortney JA
Neurogenetics; 2006 May; 7(2):81-91. PubMed ID: 16525850
[TBL] [Abstract][Full Text] [Related]
5. Muscle specific kinase protects dystrophic mdx mouse muscles from eccentric contraction-induced loss of force-producing capacity.
Trajanovska S; Ban J; Huang J; Gregorevic P; Morsch M; Allen DG; Phillips WD
J Physiol; 2019 Sep; 597(18):4831-4850. PubMed ID: 31340406
[TBL] [Abstract][Full Text] [Related]
6. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
[TBL] [Abstract][Full Text] [Related]
7. Isometric resistance training increases strength and alters histopathology of dystrophin-deficient mouse skeletal muscle.
Lindsay A; Larson AA; Verma M; Ervasti JM; Lowe DA
J Appl Physiol (1985); 2019 Feb; 126(2):363-375. PubMed ID: 30571283
[TBL] [Abstract][Full Text] [Related]
8. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
9. Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice.
Boulanger Piette A; Hamoudi D; Marcadet L; Kyomi Labelle F; Ovidiu David R; Bossé S; Argaw A; Frenette J
PLoS One; 2018; 13(6):e0198408. PubMed ID: 29879154
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of weakness in Mdx muscle following in vivo eccentric contractions.
Baumann CW; Ingalls CP; Lowe DA
J Muscle Res Cell Motil; 2022 Jun; 43(2):63-72. PubMed ID: 35445349
[TBL] [Abstract][Full Text] [Related]
11. Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice.
Mueller GM; O'Day T; Watchko JF; Ontell M
Hum Gene Ther; 2002 Jun; 13(9):1081-90. PubMed ID: 12067441
[TBL] [Abstract][Full Text] [Related]
12. Effect of heart failure on skeletal muscle myofibrillar protein content, isoform expression and calcium sensitivity.
Toth MJ; Palmer BM; LeWinter MM
Int J Cardiol; 2006 Feb; 107(2):211-9. PubMed ID: 16412799
[TBL] [Abstract][Full Text] [Related]
13. Mechanical factors tune the sensitivity of mdx muscle to eccentric strength loss and its protection by antioxidant and calcium modulators.
Lindsay A; Baumann CW; Rebbeck RT; Yuen SL; Southern WM; Hodges JS; Cornea RL; Thomas DD; Ervasti JM; Lowe DA
Skelet Muscle; 2020 Feb; 10(1):3. PubMed ID: 32007101
[TBL] [Abstract][Full Text] [Related]
14. Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle.
Blaauw B; Mammucari C; Toniolo L; Agatea L; Abraham R; Sandri M; Reggiani C; Schiaffino S
Hum Mol Genet; 2008 Dec; 17(23):3686-96. PubMed ID: 18753145
[TBL] [Abstract][Full Text] [Related]
15. Dystrophin-negative slow-twitch soleus muscles are not susceptible to eccentric contraction induced injury over the lifespan of the
Kiriaev L; Kueh S; Morley JW; Houweling PJ; Chan S; North KN; Head SI
Am J Physiol Cell Physiol; 2021 Oct; 321(4):C704-C720. PubMed ID: 34432537
[TBL] [Abstract][Full Text] [Related]
16. TAT-μUtrophin mitigates the pathophysiology of dystrophin and utrophin double-knockout mice.
Call JA; Ervasti JM; Lowe DA
J Appl Physiol (1985); 2011 Jul; 111(1):200-5. PubMed ID: 21565990
[TBL] [Abstract][Full Text] [Related]
17. Loss of peroxiredoxin-2 exacerbates eccentric contraction-induced force loss in dystrophin-deficient muscle.
Olthoff JT; Lindsay A; Abo-Zahrah R; Baltgalvis KA; Patrinostro X; Belanto JJ; Yu DY; Perrin BJ; Garry DJ; Rodney GG; Lowe DA; Ervasti JM
Nat Commun; 2018 Nov; 9(1):5104. PubMed ID: 30504831
[TBL] [Abstract][Full Text] [Related]
18. Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice.
Hayes A; Williams DA
Clin Exp Pharmacol Physiol; 1994 Oct; 21(10):757-65. PubMed ID: 7867226
[TBL] [Abstract][Full Text] [Related]
19. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
Tidball JG; Wehling-Henricks M
Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
[TBL] [Abstract][Full Text] [Related]
20. Functional substitution by TAT-utrophin in dystrophin-deficient mice.
Sonnemann KJ; Heun-Johnson H; Turner AJ; Baltgalvis KA; Lowe DA; Ervasti JM
PLoS Med; 2009 May; 6(5):e1000083. PubMed ID: 19478831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
